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The preimplantation embryo floats freely within the oviduct and is capable of developing into a blastocyst independently of the maternal
reproductive tract. While establishment of the trophoblast lineage is dependent on expression of developmental regulatory genes, further
differentiation leading to blastocyst implantation in the uterus requires external cues emanating from the microenvironment. Recent studies
suggest that trophoblast differentiation requires intracellular signaling initiated by uterine-derived growth factors and integrin-binding
components of the extracellular matrix. The progression of trophoblast development from the early blastocyst stage through the onset of
implantation appears to be largely independent of new gene expression. Instead, extrinsic signals direct the sequential trafficking of cell
surface receptors to orchestrate the developmental program that initiates blastocyst implantation. The dependence on external cues could
coordinate embryonic activities with the developing uterine endometrium. Biochemical events that regulate trophoblast adhesion to
fibronectin are presented to illustrate a developmental strategy employed by the peri-implantation blastocyst.
D 2005 Elsevier Inc. All rights reserved.
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The trophoblast lineage is responsible for sustaining a
mammalian conceptus throughout gestation. Beginning with
their progenitors derived from the outer layer of the
preimplantation embryo, the trophectoderm, trophoblast
cells perform a multitude of functions essential for
blastocyst formation, implantation, and placentation. At
the late blastocyst stage, the trophoblast attaches to the
endometrium and invades through the uterine epithelium to
infiltrate the interstitium (Carson et al., 2000). Blastocyst
implantation is the initial step of placentation and the
trophoblast comprises a major component of the placenta.
Trophoblast cells differentiate into several subtypes that0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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E-mail address: d.armant@wayne.edu.serve a variety of functions, including invasive remodeling
of the maternal vasculature and molecular transport at the
maternal–fetal interface (Adamson et al., 2002; Pijnenborg
et al., 1981). Thus, the trophoblast is ultimately responsible
for ensuring adequate flow of maternal blood to the
placenta, as well as shuttling nutrients, gases, and waste
products between maternal and fetal blood.
While the complexity of trophoblast differentiation has
been well described, the biochemical mechanisms that guide
trophoblast development are still the subject of intense
investigation. For example, it is clear that trophoblast stem
cells are capable of converting to diverse phenotypes
depending on where in the conceptus they are located. But
how does cell position determine cell behavior? What is the
molecular basis of the phenotypic plasticity of the tropho-
blast? Differentiation of the many trophoblast subtypes, as
described below, is highly complex, making these questions
difficult to answer. The major influence of extrinsic signals280 (2005) 260–280
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their sensitivity to positional information. The molecular
(Cross, 2000; Kunath et al., 2004; Red-Horse et al., 2004)
and cellular (Denker, 1993; Sutherland, 2003) aspects of
trophoblast differentiation based on studies in experimental
species have been detailed in previous reviews. Here, we
will examine trophoblast differentiation during blastocyst
implantation in mice with respect to mechanisms that
regulate their adhesion to the extracellular matrix (ECM)
as they commence invasion of the endometrium. The
biochemical process that establishes trophoblast adhesion
provides a paradigm for understanding how the maternal
and embryonic developmental programs operate in har-
mony. Trophoblast cells incorporate specific molecular cues
obtained from their surroundings to advance stepwiseFig. 1. Maternal–embryonic interactions during peri-implantation development. (A
(yellow shading) to the adhesion competent stage, but extrinsic factors (intersecting
of the extrinsic factors is altered by embryo location and by physiological change
trophoblast differentiation and induce cell competence for subsequent interactions
(GFs) and other soluble bioactive molecules secreted by the oviduct and uterus p
trafficking to the surface of trophoblast cells to activate receptors for new extrins
occur at the interacting surfaces of trophoblast and luminal epithelial (LE) cells.
blastocyst adhesion to the ECM. As the blastocyst invades through the LE, contact
required for strong trophoblast adhesion and subsequent invasion of the decid
differentiation of trophoblast cells along several divergent developmental pathwatoward an invasive phenotype. Through this directed
process, trophoblast behavior can be intricately coordinated
with changing conditions in the endometrium. Similar
interactive strategies could guide other aspects of tropho-
blast development and conversion to trophoblast subtypes
during placentation.
The maternal–embryonic dialogue
Blastocyst implantation is dependent on the intrinsic
embryonic program, operating in conjunction with extrinsic
signals emanating from the female reproductive tract
(Fig. 1A). Uterine-derived signals maintain the pace of
blastocyst development and mobilize embryonic receptors
used for subsequent signaling (Armant et al., 2000).) The intrinsic developmental program will direct blastocyst differentiation
yellow arrows) impact the outcome. As development progresses, the nature
s in both embryonic and uterine tissues. These signals accelerate the rate of
with other extrinsic signals by mobilizing new receptors. (B) Growth factors
rovide paracrine signals to the embryo. These signals could trigger protein
ic signals. After hatching from the zona pellucida, juxtacrine signaling can
Integrin trafficking induced by these interactions imparts competence for
with the basement membrane and decidual ECM activates integrin signaling
ua. Later during placentation, extrinsic signaling could account for the
ys.
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the blastocyst (Psychoyos, 1973). The presence of a
blastocyst is required for uterine expression of heparin-
binding EGF-like growth factor (HB-EGF), followed by
production of betacellulin, epiregulin, neuregulin-1, and
cyclooxygenase-2 as the blastocyst attaches to the luminal
epithelium (Dey et al., 2004). This molecular dialogue
serves to synchronize embryonic and maternal tissues
during the peri-implantation period. Like the mature oocyte,
the blastocyst is primed to advance in development only
after it receives an external signal. Rather than a sperm, the
blastocyst awaits contact with the receptive endometrium.
As in the developing zygote, blastocyst differentiation relies
on transcripts synthesized at a prior stage (Armant et al.,
2000; Schindler and Sherman, 1981). In this article,
evidence will be reviewed illustrating that crucial gene
products required for blastocyst implantation are activated
only after the endometrium signals its readiness.
Mammals have evolved to sequentially deliver extrinsic
signals to the preimplantation embryo by taking advantage
of its location within the reproductive tract, temporal
changes in the endometrium, and accessibility of embryonic
cells to maternal compartments. Preimplantation embryos
are initially surrounded by an ECM, the zona pellucida, that
limits paracrine signaling; only soluble molecules present in
fluids of the oviduct and uterus can penetrate the zona and
reach the embryo (Fig. 1B). Once freed of the zona
pellucida, the blastocyst can interact directly with cells
and tissues. Growth factors tethered to cell surfaces become
accessible for juxtacine signaling (Fig. 1B), widening the
scope of interactions. For example, epithelial cells adjacent
to the hatched blastocyst produce the transmembrane form
of HB-EGF, which activates receptors on the surface of
trophoblast cells (Raab et al., 1996). HB-EGF accelerates
the rate of blastocyst differentiation in vitro, in part by
stimulating a5h1 integrin trafficking to the apical surface of
trophoblast cells (Wang et al., 2000). Later, the epithelial
cells adjacent to the embryo are lost and ECM components
of the underlying basement membrane become accessible to
the trophoblast (Fig. 1B). We will discuss in this article how
integrin signaling mediated by a5h1 mobilizes other
integrins that strengthen trophoblast adhesion to fibronectin.
An important second messenger integrating signals that
reach the embryo from both growth factors and ECM is
Ca2+, which plays a similar role in egg activation by
initiating protein trafficking. The fine-tuning of trophoblast
differentiation by extrinsic signals orchestrates the molec-
ular interactions required for implantation in a precise and
metabolically efficient sequence.
A brief overview of trophoblast differentiation
Trophectoderm is the first polarized epithelium to appear
during mammalian development. It emerges through the
assembly of tight cellular junctions and inward movement
of water to generate the large cavity characteristic of ablastocyst (Collins and Fleming, 1995; Watson and Bar-
croft, 2001). The trophectoderm does not contribute any
tissues to the fetus, but rather establishes the trophoblast
lineage that produces the placenta and extraembryonic
membranes. The fetus is derived solely from a cluster of
non-polar, pluripotent cells situated eccentrically within the
blastocyst, the inner cell mass (ICM).
At the implantation stage in mice, mural trophoblast cells
(those not contacting the ICM) differentiate into primary
trophoblast giant cells (TGCs) that undergo endoreduplica-
tion and initiate invasion of the endometrium (Dickson,
1963; Kirby et al., 1967). The primary TGCs anchor the
embryo in the uterine wall and form the outermost layer of
the parietal yolk sac (Cross et al., 1994; Gardner et al.,
1973). The polar trophoblast cells remain diploid due to
signals, including fibroblast growth factor-4 (FGF-4), they
receive from the adjacent ICM (Chai et al., 1998; Tanaka et
al., 1998). As polar trophoblast cells proliferate, those
displaced away from the ICM are incorporated into the
mural trophoblast and differentiate into primary TGCs
(Gardner, 2000).
During mouse placentation, components of the ICM and
polar trophoblast develop into the extraembryonic ectoderm
and ectoplacental cone (EPC), respectively (Adamson et al.,
2002; Gardner et al., 1973). Stem cells residing in the
extraembryonic ectoderm provide a reservoir of trophoblast
cells for the growing placenta (Tanaka et al., 1998). The
core of the EPC contains diploid trophoblast cells that form
the outer spongiotrophoblast and inner labyrinthine layers of
the placenta. In the labyrinthine layer, the site of exchange
between maternal and fetal blood, diploid trophoblast cells
fuse to form syncytiotrophoblasts. At midgestation, a
population of trophoblast glycogen cells appears transiently
within the spongiotrophoblast layer and invade out to the
distal regions of the decidua (Adamson et al., 2002; Redline
and Lu, 1989). Trophoblast cells at the periphery of the
placenta differentiate into secondary TGCs that closely
resemble the primary TGCs. Secondary TGCs secrete
hormones, including placental lactogens and proliferin,
and invade the uterine arteries (Adamson et al., 2002; Faria
et al., 1990). Using laboratory animal models and tropho-
blast stem cells induced to differentiate in vitro, genes have
been described that determine each phenotype, ranging from
undifferentiated trophoblast stem cells to syncytiotropho-
blasts and TGCs (Rossant and Cross, 2001). These
discoveries reveal the importance of intercellular signaling
in placental morphogenesis.
Blastocyst implantation
Conversion of trophoblast cells to an adhesive phenotype
during peri-implantation development proceeds in a step-
wise fashion that is coordinately regulated with endometrial
differentiation, as depicted in Fig. 1B. It is crucial that the
blastocyst becomes competent for implantation during the
brief bwindowQ of uterine receptivity for implantation (Paria
D.R. Armant / Developmental Biology 280 (2005) 260–280 263et al., 1993). The process of implantation may be subdivided
into phases delineated by critical cellular interactions
between the trophoblast and uterine endometrium (Schlafke
and Enders, 1975). Initially, tight apposition occurs between
the embryo and uterine epithelium as the blastocyst lodges
in a crypt of the uterine folds and localized edema of the
endometrium molds an implantation chamber around the
embryo. During this period, the blastocyst hatches from the
zona pellucida. The apical surface of the mural trophoblast
then attaches to the opposing surface of the luminal
epithelium. Blastocyst attachment initiates decidualization
of fibroblast cells in the surrounding endometrial stroma.
The attachment reaction is followed by apoptosis of those
luminal epithelial cells contacting the blastocyst, providing
access to the underlying basement membrane. In the final
stage, trophoblast cells undergo changes in cell polarity and
adhesiveness, allowing them to complete their differentia-
tion to the invasive phenotype. Invading trophoblast cells
breach the uterine basement membrane to infiltrate the
decidua.
While trophoblast differentiation at implantation varies
among species, the general processes of apposition, attach-
ment, acquisition of apical adhesiveness, and invasion apply
to human embryos, as well as mice. The basolateral surfaces
of undifferentiated trophectoderm cells adhere to a basement
membrane that surrounds the blastocyst cavity, but their
apical surfaces are non-adhesive, typical of epithelial cells.
After the blastocyst hatches from the zona pellucida, the
apical surface of the mural trophoblast differentiates
(Armant et al., 1986a; Sherman and Atienza-Samols,
1978), altering its ability to interact with other cells or
ECM. Efforts in the past two decades have focused on
understanding the ontogeny of adhesive mechanisms on the
apical surface of trophoblast cells during this brief period of
development. These changes are critical for the transition
from an epithelial trophectoderm to the invasive TGC
phenotype responsible for blastocyst implantation.Table 1
Pre- and peri-implantation mouse embryonic developmental rates in vivo
and in vitro
Embryonic stage Time
in vivo
Time
in vitro
Fertilization E0
2-Cell embryo E1.0
Compacted 8-cell embryo E2.5
Early blastocyst E3.5 GD4
Expanded blastocyst and hatching E3.8 GD5
Attachment reaction/attachment competent E4.0 GD6
At basement membrane/adhesion competent E5.2 GD7
Invasion of stroma/trophoblast outgrowth E6.2 GD7–10
For in vitro culture, blastocysts are removed from the uterus on embryonic
day (E) 3.5 and then cultured on a surface treated with fibronectin in serum-
free medium, beginning on gestation day (GD) 4. Note that E3.5 is noon of
GD4.Experimental approaches for investigating implantation
The initial stages of implantation are largely unknown in
humans due to ethical limitations on experimentation. Most
of our understanding of blastocyst development and early
trophoblast differentiation derives from work with animal
models, including non-human primates, livestock, and
rodents (Carson et al., 2000). Owing to its small diameter
(approx. 100 Am) and location within a relatively large
uterine lumen, the implanting mouse blastocyst is a rather
intractable subject for in utero biochemical approaches. To
explore the embryonic side of implantation, the in vitro
culture of blastocysts has provided a useful experimental
tool. Newly formed blastocysts are flushed from the uterus
on embryonic day 3.5 (E3.5), initiating in vitro culture on
gestation day 4 (GD4, where a copulatory plug is found on
GD1). The two conventions for marking time are used hereto distinguish in vivo (E) from in vitro (GD) development.
Cultured blastocysts recapitulate many of the peri-implan-
tation stages that occur in utero, but at a considerably slower
rate (Table 1).
The central event of peri-implantation embryonic devel-
opment is the conversion of the apical domain of the
trophoblast plasma membrane to an adhesive surface.
Initially, trophoblast cells are not reactive with maternal
cells or ECM. As the trophoblast differentiates, the apical
surface first becomes attachment competent, acquiring
receptors that mediate interactions with the uterine luminal
epithelium. The attachment reaction appears to be governed
by a broad variety of molecules that inhibit or promote the
attachment of trophoblast to uterine epithelial cells (Dey et
al., 2004; Kimber, 2000; Kimber and Spanswick, 2000). In
the next step, the blastocyst becomes adhesion competent by
activating receptors for ECM on the apical surface of
primary TGCs. Trophoblast adhesion to the uterine base-
ment membrane and interstitial ECM has been particularly
amenable to study in vitro. Blastocysts become adhesion
competent in serum-free medium on GD7 (Table 1) and
quickly undergo trophoblast dispersion and migration to
form an outgrowth on surfaces coated with adhesive
proteins (Armant et al., 2000).
Using the in vitro experimental approach, a great deal of
biochemical information has accumulated, indicating the
nature and molecular basis of embryo-endometrial inter-
actions during implantation, as outlined in Fig. 1. Adhesive
mechanisms can be analyzed by perturbing trophoblast
outgrowth with specific reagents to yield information about
the processes that directly mediate trophoblast adhesion
(Wang and Armant, 2002) and the developmental program
that converts trophoblast cells from an epithelial phenotype
to invasive cells (Armant et al., 2000). Combined with data
on the in utero localization of key proteins, experimental
studies of blastocysts in culture have revealed novel
mechanisms that orchestrate adhesive interactions of pri-
mary TGCs with molecular components of the uterine
endometrium during implantation.
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The culture of blastocysts in vitro and formation of
trophoblast outgrowths was first developed in the 1960s as
an in vitro model of implantation (Gwatkin, 1966; Gwatkin
and Meckley, 1966). Trophoblast outgrowth is easily
observed during blastocyst culture as a spreading monolayer
of cells around the base of the embryo concomitant with
disappearance of the spherical blastocyst morphology. This
experimental approach was used by several laboratories to
examine morphological and biochemical aspects of peri-
implantation blastocyst development (Enders et al., 1981;
Sherman and Atienza-Samols, 1978; Spindle and Pedersen,
1973; Surani, 1979). Although there was much interest in
understanding the molecular basis of trophoblast adhesion
in vitro, the original media used for blastocyst culture was
supplemented with serum, which contains adhesive ECM
components, including fibronectin and vitronectin. For this
approach to be viable, it was necessary to develop more
defined culture conditions. Toward that end, successful
trophoblast outgrowth was reported in serum-free medium
when culture plates were coated with collagen (Jenkinson
and Wilson, 1973; Wordinger and McGrath, 1979), estab-
lishing that a major function of serum was the provision of a
biologically active substrate for cell adhesion. Later,
fibronectin, laminin, vitronectin, entactin/nidogen, and other
ECM components were used as surface coatings to generate
trophoblast outgrowths in defined, serum free-medium for
the purpose of understanding the biochemical basis of
trophoblast adhesion to specific ECM proteins (Armant et
al., 1986a,c; Yelian et al., 1993).
Trophoblast cells adhere to complex ECM and basement
membranes (Cammarata et al., 1987; Wordinger et al.,
1991), and are capable of differentiating on and migrating
through ECM purified from mouse endometrium (Armant
and Kameda, 1994). Ultrastructural evidence has established
that mouse trophoblast cells adhere to the uterine basement
membrane around E5.2 in vivo (Blankenship and Given,
1992), after the juxtaembryonic uterine epithelium is lost to
apoptosis (Schlafke et al., 1985; Parr et al., 1987; Welsh and
Enders, 1991). During blastocyst implantation, the newly
formed decidua secretes a rich ECM composed of collagens,
proteoglycans, fibronectin, laminin, and entactin/nidogen
(Kisalus et al., 1987; Leivo et al., 1980; Rider et al., 1992;
Wartiovaara et al., 1979; Wewer et al., 1986; Wu et al.,
1983), which are available to support trophoblast adhesion
during the invasive phase. Therefore, the interactions
observed between trophoblast cells and ECM components
in vitro most likely correspond to adhesive interactions that
occur in utero as the primary TGCs initially adhere to the
basement membrane and commence their invasion of the
underlying decidua. A challenge to investigators is to
understand how trophoblast cells efficiently adhere to the
complex mixture of ECM proteins encountered in vivo.
Studies of adhesion to fibronectin, described below, provide
some insight into how that could be accomplished.Trophoblast integrins
While many classes of proteins participate in tropho-
blast–epithelial interactions during the attachment reaction
(Dey et al., 2004; Kimber, 2000), trophoblast adhesion to
ECM appears to be mediated predominantly by integrins
(Sutherland, 2003; Wang and Armant, 2002). Integrins are a
family of heterodimeric (a/h) transmembrane glycoproteins
that bind extracellularly to the ECM and intracellularly to
adapter proteins that link them to cytoskeletal and signaling
proteins (Giancotti and Ruoslahti, 1999; Hynes, 2002). A
role for integrins in trophoblast adhesion was initially
implicated by the inhibitory activity of an antibody
(GP140) recognizing a complex of integrins (Richa et al.,
1985) and a small peptide (GRGDSP) representing a
sequence within the tenth type III homology repeat of
fibronectin (FIII-10) recognized by integrins (Armant et al.,
1986c). Conversely, trophoblast outgrowth on fibronectin is
specifically inhibited by a peptide corresponding to the
region of the h1 integrin subunit that recognizes the RGD
sequence (Shiokawa et al., 1999). The RGD sequence
appears in other ECM proteins and mediates their binding to
integrins during cell adhesion cooperatively with other
sequence motifs (Plow et al., 2000; Ruoslahti, 1996). The
peptide GRGDSP specifically inhibits trophoblast out-
growth on fibronectin, vitronectin, type II collagen, and
entactin/nidogen (Armant et al., 1986c; Carson et al., 1988;
Yelian et al., 1993). However, outgrowth on laminin 1 is not
blocked by this peptide (Armant et al., 1986c). The E8
domain of laminin 1, which is devoid of an RGD sequence,
is responsible for that outgrowth activity (Armant, 1991).
Evidence suggests that mouse trophoblast cells adhere to
laminin 1 through the a7h1 integrin (Klaffky et al., 2001).
The diverse array of adhesive ECM ligands and integrin
receptors provides functional redundancy to ensure that
trophoblast cells are able to adhere to and invade the
interstitial components of the endometrium. A challenge for
investigators is to now decipher individual roles of the ECM
components in directing the movements and organization of
trophoblast cells during placentation. Studies of knockout
mice lacking specific laminin subunits suggest that laminin
isoforms have different functions in directing trophoblast
morphogenesis (Miner et al., 2004). Transgenic models like
these could be useful for revealing the physiological impact
of interactions between specific integrin–ligand partners.
Based on experiments using proteolytic fragments of
fibronectin and peptide inhibitors, the specific target of
adhering primary TGCs has been defined as the RGD site in
a 120-kDa fragment of fibronectin (FN-120) containing the
FIII-10 repeat (Yelian et al., 1995). Adhesion is unsupported
by another fragment containing the IIICS segment, which
serves as an alternate (non-RGD) cell recognition site.
These findings are consistent with the observed expression
in mouse preimplantation embryos of RGD-recognizing
integrins (a5h1, aVh3, and aIIbh3), but not a4h1 or a4h7
that recognize the IIICS repeat of fibronectin (Schultz et al.,
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a4 is expressed on E8.0 in the chorion, and a4 integrin-
mediated adhesion is indispensable for chorio-allantoic
union (Downs, 2002; Yang et al., 1995). Many integrins
are expressed as early as the oocyte stage, including the
subunits a5, a6, aV, h1, and h3 (Evans et al., 1995; Fusi et
al., 1993; Hierck et al., 1993; Sutherland et al., 1993; Tarone
et al., 1993), demonstrating that the preimplantation embryo
accumulates integrins capable of binding to fibronectin and
other ECM proteins long before the implantation stage.
Although integrin genes are highly expressed during
preimplantation development, we will see that the presence
of integrin proteins at the outer surface of the embryo is
restricted. Integrin trafficking appears to be a rate-limiting
step in establishing blastocyst adhesion to the ECM.
As adherent cells spread and migrate, integrins are first
clustered in the plasma membrane and then organized into
focal adhesions that anchor the actin cytoskeleton to the
ECM to regulate cell shape and migration (Sastry and
Burridge, 2000). a5h1, aVh3, and aIIbh3 all appear in
focal adhesions formed by trophoblast cells during fibro-
nectin-mediated outgrowth, and blocking antibodies against
the h1 or h3 subunits delay outgrowth (Rout et al., 2004;
Sutherland et al., 1993; Yelian et al., 1995). Although gene
knockout studies suggest that none of these integrins are
essential for implantation (Hynes, 1996), the three integrins
appear to operate synergistically in trophoblast cells adher-
ing to fibronectin (Rout et al., 2004). Details of the latter
study will be discussed below.
Determining the onset of blastocyst adhesion
A more refined approach than the blastocyst outgrowth
model is required to investigate the adhesive activity of
integrins at the apical surface of mural trophoblast cells
before they dissociate and migrate outward. To address this
dilemma, a fibronectin-binding assay was devised using
fluorescent polystyrene microspheres coated with FN-120
that are incubated for 30 min at 48C with intact blastocysts
(Schultz and Armant, 1995). The fibronectin-binding assay
is ideal to investigate the onset of adhesion at the apical
surface of trophoblast cells, since it is performed rapidly
and detection does not require any cellular activity beyond
ligand binding. Image analysis is used to quantify the
intensity of the fluorescence imparted by the bound
microspheres. Binding is restricted to the mural trophoblast
where TGCs first differentiate. The specificity of fibronec-
tin-binding activity is demonstrated by competitive inhib-
ition with FN-120 or the GRGDSP peptide, but not other
proteins or fragments of fibronectin lacking FIII-10.
Importantly, binding activity is specifically blocked by
antibodies against the integrin subunits a5, aV, aIIb, h1,
and h3, which comprise the RGD-recognizing integrins
a5h1, aVh3, and aIIbh3 (Rout et al., 2004; Schultz and
Armant, 1995). The fibronectin-binding assay provides an
important tool for assessing the adhesive activity ofintegrins on the embryo surface during peri-implantation
development. The assay is useful for comparative analysis
of adhesion throughout development if embryos are first
treated with heparinase to eliminate microsphere binding to
heparan sulfate proteoglycans. As would be expected,
fibronectin-binding activity parallels trophoblast outgrowth
by first appearing on GD7 (Schultz et al., 1997). Agonists
capable of accelerating the rate of blastocyst outgrowth
concomitantly shift the onset of fibronectin-binding activity
from GD7 to GD6, substantiating the physiological
relationship between this activity and the adhesion com-
petence of blastocysts (Wang et al., 1998, 1999, 2000).
Molecular interactions between the trophoblast and
fibronectin
Fibronectin is abundant in the mouse endometrial base-
ment membrane and stromal ECM on E4.5–E5.5, when the
trophoblast breaches the luminal epithelium and commences
invasion (Wartiovaara et al., 1979). As peri-implantation
development proceeds, fibronectin accumulates in the ECM
subjacent to the basement membrane and becomes remod-
eled in the stroma (Rider et al., 1992; Slater and Murphy,
1999). In vitro studies of mouse E7.0 decidua explants
reveal constitutive levels of fibronectin synthesis and
deposition (Babiarz et al., 1996), indicative of its dynamic
role during blastocyst implantation. Other ECM compo-
nents, including laminins and collagens, also undergo
remodeling (Farrar and Carson, 1992; Glasser et al., 1987;
Wewer et al., 1986) and are deposited in isoform-specific
patterns that could influence trophoblast morphology as
placentation commences (Miner et al., 2004). Fibronectin
colocalizes with invasive extravillous trophoblast cells of
the early human implantation site (Earl et al., 1990;
Feinberg et al., 1991) and it promotes anchorage of
placental villous explants (Aplin et al., 1999). Some in
vitro experiments suggest that fibronectin promotes troph-
oblast adhesion, which may restrict migration, while other
studies indicate that it facilitates motility (Burrows et al.,
1993; Damsky et al., 1994; Irving et al., 1995; Stephens et
al., 1995; Yelian et al., 1995). Fibronectin has the ability to
modulate both integrin-mediated adhesion (detailed below)
and protease activity (Zhang et al., 1996) of trophoblast
cells. In vivo, it could have diverse functions at different
locations within the implantation site, depending on integrin
expression and proximal levels of matrix-degrading pro-
teases. Therefore, fibronectin is a relevant and instructive
model ligand for studies of mouse primary TGC adhesion to
ECM.
A key question addressed in studies of trophoblast
interactions with fibronectin is how the non-adhesive
surface of the early blastocyst acquires its adhesiveness
during peri-implantation development. Since some fibro-
nectin-binding integrins are expressed on the apical surface
earlier during development, it is important to understand
exactly how their activities are regulated during conversion
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presented here suggests that trophoblast differentiation is
controlled at three levels: (1) the intrinsic developmental
program of the blastocyst, (2) responses to extrinsic
developmental triggers, and (3) subsequent autocrine signal-
ing by the trophoblast to reinforce extrinsic input.Table 2
Effect of metabolic inhibitors on trophoblast differentiation
Stage of development Effective
inhibitors
Required metabolic
processes
Late cavitation (GD3) a-Amanitin mRNA transcription
Early blastocyst (GD4) Cycloheximide Protein synthesis
Mid-blastocyst (GD5–6) Tunicamycin N-glycosylation
Late blastocyst (GD6–7) Brefeldin A Protein trafficking
Adhesion competent (GD7)
[exposed to fibronectin]
Brefeldin A Protein trafficking
Morulae or blastocysts cultured to GD7 were inhibited in their ability to
express strong fibronectin-binding activity or form trophoblast outgrowths
when treated during the indicated stages of embryonic development with
the metabolic inhibitors shown. Cycloheximide and a-amanitin were both
ineffective when used before or after the indicated stages.Regulation of adhesion by the intrinsic developmental
program
It is first important to establish the nature of the intrinsic
program that advances development during the blastocyst
stage in the context of trophoblast adhesiveness to
fibronectin. What cellular processes are required to unfold
the entire program? Is progression through the peri-
implantation period dependent on new gene expression?
Assessments of outgrowth and fibronectin-binding activity
have been used in conjunction with metabolic inhibitors to
examine the role of gene transcription, translation, and
protein trafficking in regulating trophoblast development.
Regulation of gene expression
The RNA polymerase II inhibitor, a-amanitin, was ori-
ginally found to have no effect on blastocyst outgrowth
when present during any 24-h period between GD4 and GD7
(Schindler and Sherman, 1981). A less specific inhibitor of
transcription, actinomycin D, is also a poor inhibitor of
trophoblast outgrowth (Glass et al., 1976). Conditions of a-
amanitin treatment have been established that completely
inhibit poly(A+) RNA synthesis within 3 h in mouse
blastocysts without affecting total RNA synthesis (Khidir
et al., 1995). Culture of blastocysts with a-amanitin between
GD4 and GD7 has no effect on the appearance of
fibronectin-binding activity early on GD7 (Schultz et al.,
1997), suggesting that genes regulating trophoblast adhesion
are expressed prior to the early blastocyst stage, over 72 h
before the event occurs. De novo gene expression during the
blastocyst stage could impact ICM development, TGC
endoreduplication, or postimplantation events, but appears
to have little effect on the progression of trophoblast cells
through adhesion and outgrowth.
The congruent findings of Schindler and Sherman
(1981) and Schultz et al. (1997) stand in stark contrast
to transcriptional inhibition studies at an earlier devel-
opmental stage. Treatment of 16-cell morulae with a-
amanitin within 2 h of the onset of cavitation inhibits
blastocyst formation (Khidir et al., 1995; Kidder and
McLachlin, 1985), demonstrating temporal regulation by
de novo gene expression. The effectiveness of a-amanitin
at the 16-cell morula stage diminishes concern that the
drug failed to inhibit transcription of critical genes at the
blastocyst stage, and strengthens the view that adhesive
differentiation of the trophoblast relies on genes expressed
earlier during development.So when are the genes that direct this aspect of
trophoblast development transcribed? This question can be
addressed by collecting embryos 24 h earlier, at the morula
stage, for treatment with a-amanitin. Embryos exposed for 8
h to a-amanitin late on GD3, but not earlier in the day,
exhibit significantly reduced fibronectin-binding activity
after culture to GD7 (Schultz et al., 1997). This experiment
defines a brief period during blastocyst formation when
genes required several days later for trophoblast adhesion to
fibronectin are transcribed. Based on similar experiments
using cycloheximide, it has been determined that the period
of development when protein synthetic activity is required
for trophoblast adhesion occurs late (between 16 and 24 h)
on GD4 (Schultz et al., 1997), which is in agreement with an
earlier investigation that measured outgrowth rates (Blake et
al., 1982). Results of studies using a-amanitin and cyclo-
heximide suggest that genes required for the adhesive and
migratory activity of primary TGCs are translated about 24
h after they are transcribed (Table 2). Whether the tran-
scripts are sequestered as ribonucleoprotein complexes for
later translation is not known.
Global gene expression analysis of preimplantation
development using microarrays indicates that relatively
few mRNAs increase in abundance after the 8-cell stage
(Hamatani et al., 2004a) with the possible exception of a
burst of transcript accumulation between the 16-cell and
blastocyst stages (Wang et al., 2004), the period of
development when a-amanitin impacts trophoblast differ-
entiation. The 16-cell morula to 32-cell blastocyst transition
encompasses the period of outer cell commitment to the
trophoblast lineage, since blastomeres at the 16-cell stage
retain totipotency (Ziomek et al., 1982). Therefore, it is not
surprising that transcription at that time is critical for
trophoblast function. Discerned patterns of global gene
expression during the preimplantation period support a
bwave of activationQ hypothesis in which transcription of
gene clusters occurs well before execution of their devel-
opmental function (Hamatani et al., 2004a). Trophoblast
adhesion at implantation appears to be regulated in this
manner.
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are the caudal-related homeodomain transcription factor,
Cdx2 (Chawengsaksophak et al., 1997), and the mouse
homologue of a T-box transcription factor, eomesodermin
(mEomes) (Russ et al., 2000), which are both expressed
exclusively in the trophectoderm on E3.5 (Beck et al.,
1995; Hancock et al., 1999). Blastocysts lacking either of
these genes fail to outgrow in vitro. Later, the genes are
expressed in the extraembryonic ectoderm in response to
FGF-4 signaling and are downregulated as trophoblast
stem cells differentiate (Cross, 2000; Tanaka et al., 1998).
The regulation of Cdx2 and mEomes and the identity of
their target genes are not well understood. Cdx2 is
involved in mesodermal pattern formation and activates
expression of certain Hox genes (Lohnes, 2003). mEomes
is associated with mesoderm differentiation from the
epiblast at gastrulation and induction of genes regulating
mesoderm migration (Showell et al., 2004). Sutherland
(2003) points out that both trophoblast and pre-meso-
dermal epiblast cells express mEomes and subsequently
undergo an epithelial to mesenchymal transition. Expres-
sion patterns obtained by microarray-based gene tran-
scription profiling show a sudden accumulation of Cdx2
and mEomes between the 16-cell and blastocyst stages
(Wang et al., 2004), suggesting that these regulatory genes
are activated during blastocyst formation. It is thought that
their expression in trophectoderm cells confers the ability
to differentiate into trophoblast. Implantation rescue of
Cdx2 null embryos by aggregation with wild type
tetraploid blastomeres demonstrates that trophoblast failure
is directly responsible for the implantation defect in
mutant blastocysts (Chawengsaksophak et al., 2004).
The putative functions of Cdx2 and mEomes and their
patterns of expression support the prediction of a-
amanitin experiments that transcription during blastocyst
formation is requisite for trophoblast adhesive and
migratory activities (Schindler and Sherman, 1981;
Schultz et al., 1997).
Post-translational regulation
Presumably, genes activated during blastocyst forma-
tion, together with other embryonic gene products,
perform the work of transforming trophoblast cells to
the invasive phenotype. Since the embryonic program
operates without further need for transcription or protein
synthesis, post-translational mechanisms must temporally
regulate peri-implantation development. During this period
of 48–72 h, the apical surface of the trophoblast cell
undergoes sequential modifications that direct blastocyst
hatching from the zona pellucida, attachment competence,
adhesion to ECM, and invasive activity. Protein turnover,
glycosylation, and trafficking are among the metabolic
processes that could direct trophoblast differentiation
during this period in the absence of further genetic
instruction.Trophoblast differentiation could be regulated in the
absence of new gene induction through the degradation of
RNA or proteins that maintain the non-adhesive pheno-
type. Targeted protein turnover is accomplished through
the ubiquitination pathway, which directs specific proteins
to the proteosome for degradation (Jackson et al., 2000). A
component of the ubiquitination pathway, the E2 (ubiquitin
conjugating) enzyme, is among genes induced at the early
blastocyst stage by 0.1% ethanol (Rout et al., 1997), a
treatment that activates intracellular Ca2+ signaling to
accelerate blastocyst outgrowth in vitro and increase
implantation rates in vivo (Stachecki et al., 1994).
Ubiquitinated proteins accumulate in mouse blastocysts
specifically within the trophoblast (Sutovsky et al., 2001),
indicative of an increase in protein turnover as the
trophoblast develops. Expression of Cdx2 and mEomes,
which are abundant in trophoblast stem cells of the
extraembyronic ectoderm, is downregulated during differ-
entiation to other phenotypes, including the invasive
secondary TGCs (Tanaka et al., 1998). A similar mecha-
nism operates during primary TGC differentiation in
blastocysts. As blastocysts become adhesion competent
and initiate outgrowth, strong nuclear expression of Cdx2
observed at earlier stages is downregulated (Fig. 2). The
half-life of proteins like Cdx2 that are transcribed during
blastocyst formation could regulate trophoblast differ-
entiation. Cdx2 and mEomes have been ascribed roles in
maintaining the undifferentiated trophoblast phenotype,
although no experimental evidence is available to support
this hypothesis. Without more information that specifically
addresses the role of protein turnover in the ontogeny of
trophoblast adhesion competence, this concept remains
speculative.
The oligosaccharide moieties of glycoproteins and
proteoglycans have a vital function in blastocyst attach-
ment to the uterine epithelium (Carson, 2002; Kimber,
2000), and could impact adhesion to the ECM. Genes
expressed during blastocyst formation may require post-
translational modification by asparagine (N)- or serine (O)-
linked oligosaccharides before they are fully functional.
Integrins that mediate trophoblast adhesion to the ECM are
among the proteins that require N-glycosylation (Bellis,
2004). Indeed, inhibition of N-glycosylation by treatment
with tunicamycin at the mid-blastocyst stage (see Table 2)
inhibits trophoblast outgrowth in vitro (Armant et al.,
1986b; Surani, 1979). During the blastocyst stage, there is
a sharp increase in the activity of UDP-GlcNAc: dolichol
phosphate N-acetylglucosamine-1-phosphate transferase
(GPT), a rate-limiting enzyme in the assembly of N-linked
oligosaccharide precursors bound to dolichol (Armant et
al., 1986b). Elevation of GPT enzymatic activity at the
blastocyst stage is unimpeded by a-amanitin, consistent
with the ability of trophoblast cells to differentiate
independently of de novo mRNA synthesis. Targeted
deletion of the GPT gene results in peri-implantation
lethality and generates trophoblast cells incapable of
Fig. 2. Downregulation of the Cdx2 transcription factor during primary TGC differentiation. Immunofluorescence was conducted according to published
procedures (Liu et al., 2004) using 10 Ag/ml of a mouse monoclonal antibody against the Cdx2 protein (BioGenex, San Ramon, CA) in fixed, permeablilized
blastocysts (A–D) or outgrowing trophoblast cells (E–F). For blastocysts, 1-Am optical sections were obtained by fluorescence microscopy and deconvolution,
as previously described (Liu et al., 2004). The deconvolved images were then recombined to produce a montage of the entire embryo. Mouse embryos were
obtained at the early blastocyst stage on E3.5 (A), cultured to the mid-blastocyst stage approximately 24 h before attaining adhesion competence (B), cultured
to the adhesion competent stage (C,D) or cultured on fibronectin-coated plates for 24 h after becoming adhesion competent (E,F). Nuclear localization of Cdx2
is evident in trophoblast cells before blastocysts become adhesion competent (A,B). However, the protein was dramatically downregulated in blastocysts
capable of adhesion and outgrowth. A collapsed, adhesion competent blastocyst shown in bright field (C) is devoid of labeled Cdx2 (D). Giant nuclei
(arrowheads in E) are abundant in outgrowing trophoblast cells, but none are labeled by the antibody (F). Scale bars, 30 Am, shown for blastocysts in D and for
outgrowth in F.
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requirement for N-glycosylation during implantation. The
time required for protein processing by glycosylation in the
endoplasmic reticulum and Golgi apparatus could influ-
ence the rate of development to the adhesive blastocyst
stage.
Gene products required for cell adhesion must be
processed, transported to the plasma membrane, and
assembled into functional multiprotein complexes. There-
fore, protein trafficking constitutes another level of
intrinsic regulation during trophoblast differentiation.
Brefeldin A interferes in vivo with intracellular protein
trafficking to block secretion and membrane transfer
between intracellular organelles (Klausner et al., 1992).Treatment with brefeldin A between GD6 and GD7 delays
blastocyst differentiation, reducing fibronectin-binding
activity on GD7 (Schultz et al., 1997). The effectiveness
of the drug during the period that immediately precedes
the onset of trophoblast adhesion (Table 2) indicates that
protein trafficking directly regulates blastocyst adhesion
competence. Moreover, the fibronectin-binding integrin,
a5h1, translocates to the apical plasma membrane of
trophoblast cells on GD7 coincident with the appearance
of adhesion competence (Schultz et al., 1997). Linkage
between insertion of a5h1 into the apical domain of the
plasma membrane and trophoblast adhesiveness is sup-
ported by experiments that jointly shift a5h1 trafficking
and the onset of fibronectin-binding activity from GD7 to
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development (Wang et al., 1998, 1999, 2000). mEomes
knockout blastocysts, which are incompetent to outgrow,
express a5h1 (Russ et al., 2000), but it is not known
whether the protein trafficks normally to the apical surface
of trophoblast cells. As discussed below, the trafficking of
additional integrins may be required for trophoblast
adhesion to fibronectin.
The intrinsic developmental program of the primary
trophoblast utilizes mRNAs synthesized during cavitation
and proteins that are translated shortly after blastocyst
formation, but probably not fully functional until they are
processed and transported to their sites of action. Outside of
the uterus, completion of the entire developmental process
from the time of gene activation to attaining adhesion
competence takes 3–4 days (summarized in Table 1).
However, the coordinate regulation of blastocyst and uterine
development to achieve strong adhesion between tropho-
blast cells and the endometrium requires the intervention of
extrinsic factors that modify and accelerate the embryonic
developmental program.Extrinsic factors that regulate trophoblast adhesion
Advanced blastocyst development is dependent on ex-
trinsic factors provided by the maternal reproductive tract.
Uterine growth factors alter the rate of blastocyst develop-
ment to synchronize the embryo with the bwindowQ of
uterine receptivity for implantation. Several endogenous
agonists that accelerate blastocyst development have been
identified and their impact on intracellular signaling to
regulate trophoblast differentiation has been described
(reviewed in Armant et al., 2000). As embryonic and uterine
tissues interact more intimately, additional synchronization is
achieved between trophoblast cells and the molecular milieu
of the endometrium. For example, the local ECM compo-
sition may vary as trophoblast cells begin to implant and
invade, requiring adjustments in cell surface receptors.
Evidence of the fine tuning that occurs on the surface of
the trophoblast during adhesion to fibronectin (reviewed in
Wang and Armant, 2002) suggests a mechanism that
mobilizes receptors with ligand specificity appropriate for
the composition of the ECM engaged by the cells.
Uterine products that accelerate the intrinsic program
Blastocysts cultured in serum-free medium beginning on
GD4 are adhesion competent by GD7 (Armant et al., 1986a;
Schultz et al., 1997; Yelian et al., 1995), about 24 h later
than when they would have adhered to the endometrial
ECM had they been allowed to develop in vivo (Blanken-
ship and Given, 1992). With prolonged exposure to the
maternal environment prior to in vitro culture (harvesting
blastocysts on E4.5/GD5), a5h1 trafficking to the apical
surface of trophoblast cells and blastocyst adhesion tofibronectin are achieved by GD6 (Wang et al., 2000). This
experiment demonstrates that the uterus provides an optimal
environment for development of the free-floating blastocyst.
A similar acceleration of trophoblast differentiation is
achieved when early blastocysts (E3.5) are cultured in
medium supplemented with hormones (Wang et al., 1998),
endocannabinoids (Wang et al., 1999), phospholipids (Liu
and Armant, 2004), or growth factors (Wang et al., 2000)
produced by the uterus during the peri-implantation period.
A large number of molecules produced within the uterus are
capable of accelerating preimplantation development (Arm-
ant et al., 2000; Cavagna and Mantese, 2003; Dey et al.,
2004), but discussion here will be limited to a few examples
representing the above listed categories. These bioactive
agonists account for at least some of the benefit derived
from the uterine environment.
Signaling pathways induced by bioactive factors pro-
duced in the receptive uterus activate downstream bio-
chemical steps in the intrinsic developmental program of the
blastocyst. Paracrine and autocrine signaling during the pre-
and peri-implantation periods supports embryogenesis, in
part, through the generation of intracellular Ca2+ transients
that operate downstream of at least three important agonists:
calcitonin, lysophosphatidic acid (LPA), and HB-EGF (Liu
and Armant, 2004; Wang et al., 1998, 2000). Receptors for
each protein are expressed by the mouse blastocyst.
Calcitonin and LPA bind to G protein-coupled receptors
that mobilize Ca2+ from intracellular stores through the
inositol 1,4,5-trisphosphate (IP3) pathway (Contos et al.,
2000; Goldring et al., 1993). HB-EGF also increases
intracellular Ca2+ levels, but through influx mediated by
N-type voltage-gated Ca2+ channels in the plasma mem-
brane (Wang et al., 2000). Downstream of Ca2+, both
calmodulin and protein kinase C play important roles in the
acquisition of adhesion competence by mouse blastocysts
(Armant et al., 2000). The cortical reaction in oocytes
(Abbott and Ducibella, 2001) and exocytosis in a number of
cell types follows the activation of calmodulin (Chamberlain
et al., 1995; Peters and Mayer, 1998) and protein kinase C
(Chen et al., 1999; Lan et al., 2001; Quetglas et al., 2000)
downstream of intracellular Ca2+ transients (Guo et al.,
1996; Kiraly-Borri et al., 1996). In blastocysts treated with
calcitonin or HB-EGF, the induction of a Ca2+ transient on
GD4 or GD5 leads to precocious trafficking of a5 to the
apical surface of the trophoblast on GD6, implying that
reactions downstream of cytosolic free Ca2+ control protein
trafficking required for blastocyst adhesion to fibronectin
(Wang et al., 1998, 2000). Indeed, direct pharmacological
induction of a Ca2+ transient at the early blastocyst stage
using ethanol accelerates the rate of trophoblast outgrowth
and doubles implantation rates after transferring embryos
back to the uterus (Stachecki et al., 1994).
In humans, autocrine and paracrine roles for calcitonin
and HB-EGF are prominent during implantation and
placentation. Both are expressed by the uterine epithelium
during the bwindowQ of implantation (Kumar et al., 1998;
D.R. Armant / Developmental Biology 280 (2005) 260–280270Leach et al., 1999a; Yoo et al., 1997) and HB-EGF
stimulates human blastocyst development in vitro (Chobo-
tova et al., 2002; Martin et al., 1998). In the placenta,
invasive extravillous trophoblast cells express high levels of
HB-EGF (Leach et al., 1999a) that can alter integrin
expression in cultured cytotrophoblast cells to increase their
invasive motility (Leach et al., 2004). Additionally, HB-
EGF is a survival factor (Iwamoto and Mekada, 2000) that
could moderate assaults by the maternal immune system and
other stresses encountered in the reproductive tract. It is
notable that aberrantly low levels of HB-EGF are found in
placentas of women with pre-eclampsia, a disorder asso-
ciated with poor trophoblast invasion and survival (Leach et
al., 2002).
The endocannabinoid, anandamide, accelerates blasto-
cyst development in a bimodal fashion, becoming inhibitory
at higher concentrations (Wang et al., 1999). Anandamide is
present at implantation sites, but its levels are much higher
in the interimplantation region (Schmid et al., 1997),
suggesting a role in embryo spacing within the rodent
uterus. Interestingly, at low, stimulatory levels, anandamide
has no effect on intracellular Ca2+ levels, but at high
concentrations that are detrimental to embryonic develop-
ment anandamide prevents influx of Ca2+ through voltage-
gated channels (Wang et al., 2003). Furthermore, low,
stimulatory concentrations of anandamide activate mitogen-
activated protein kinase (MAPK). Whether the Ca2+-
dependent acceleration of blastocyst development involves
MAPK is not presently known. However, pharmacological
elevation of intracellular Ca2+ levels in blastocysts increases
expression of c-Myc (Leach et al., 1999b), a MAPK
substrate that is required for preimplantation development
(Paria et al., 1992). Invasiveness of cultured human
cytotrophoblast cells stimulated by the urokinase plasmi-
nogen activator receptor is dependent on MAPK activation
downstream of an intracellular Ca2+ transient (Liu et al.,
2003). Therefore, MAPK could be a target of anandamide,
as well as agonists that stimulate trophoblast differentiation
through intracellular Ca2+ signaling.
Integration of multiple uterine signals
Temporal and spatial availability within the uterus
varies among paracrine-acting factors that influence
blastocyst development, as indicated in Fig. 1. LPA,
calcitonin, histamine, and several other bioactive agents
are secreted into the uterine fluid as the blastocyst exits
the oviduct on E3.5 (Armant et al., 2000). However, HB-
EGF is produced on E4.5 by murine uterine epithelial
cells solely at the site of blastocyst apposition (Das et al.,
1994). This transmembrane peptide can operate locally
through juxtacrine signaling to receptors on adjacent
trophoblast cells (Raab et al., 1996). The ectodomain of
HB-EGF is secreted through metalloproteinase-mediated
cleavage (Iwamoto and Mekada, 2000), but may function
as a proximal signal due to its strong binding to heparansulfate proteoglycans in the ECM. Juxtacrine signaling to
the trophoblast by HB-EGF during the attachment reaction
stimulates integrin trafficking required in the final
preparation for adhesion to the ECM and invasion of
the endometrium.
In addition to its expression in the uterus, HB-EGF is
induced in embryonic tissues during activation of dormant
blastocysts (Hamatani et al., 2004b). Embryonic HB-EGF
can potentially stimulate uterine differentiation to the
receptive state (Paria et al., 2001). We now have evidence
that autocrine signaling by HB-EGF in trophoblast cells,
as depicted in Fig. 3, could integrate diverse paracrine
signals arising from the endometrium. For example, the
Ca2+-dependent acceleration of blastocyst development by
LPA requires HB-EGF, based on the inhibitory effects of
antibodies against HB-EGF or its receptors, ErbB1 and
ErbB4 (Liu and Armant, 2004). HB-EGF trafficks from
the cytoplasm to the surface of trophoblast cells in
cultured blastocysts treated on GD5 with LPA (Fig. 3A).
G protein-coupled receptors can transactivate ErbB1 or
ErbB4 through ectodomain shedding of HB-EGF (Umata
et al., 2001). Transactivation occurs downstream to either
intracellular Ca2+ or protein kinase C activation (Dethlef-
sen et al., 1998; Dong and Wiley, 2000). The LPA-
induced trafficking of HB-EGF to the apical surface of
trophoblast cells is blocked by chelation of intracellular
Ca2+ with BAPTA-AM or by interrupting the IP3 pathway
(Liu and Armant, 2004), supporting our hypothesis that LPA
initiates Ca2+-dependent trafficking of HB-EGF to the cell
surface where it is shed by metalloproteinases (Fig. 3B) and
binds its receptors in an autocrine loop (Fig. 3C). Intra-
cellular Ca2+ signaling is also required downstream of HB-
EGF/ErbB binding (Fig. 3C) for integrin trafficking and
precocious blastocyst differentiation (Wang et al., 2000).
Blastocyst exposure to high, detrimental concentrations of
anandamide interferes with Ca2+ entry through voltage-
gated channels (Wang et al., 2003), perhaps by interrupting
autocrine HB-EGF signaling (Fig. 3C). It is plausible that
intracellular Ca2+ mobilization by other endogenous ago-
nists of G protein-coupled receptors, including calcitonin
and histamine (Goldring et al., 1993; Hill et al., 1997; Paria
et al., 1998), operate similarly through the transactivation of
ErbB receptors by HB-EGF, accounting for their similar
biological activities.
Fibronectin engagement alters blastocyst adhesion to
fibronectin
The positioning of fibronectin receptors on the surface of
the blastocyst is requisite, but not necessarily sufficient, for
strong adhesion to fibronectin. The integrin aVh3 is
available on the apical surface of trophoblast cells by
GD4 (Sutherland et al., 1993), but FN-120-coated micro-
spheres will not adhere to intact blastocysts until GD7
(Schultz and Armant, 1995). Another fibronectin-binding
integrin, a5h1, translocates to the apical plasma membrane
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1997). Although the timing of a5h1 insertion suggests that
this is required for adhesion to fibronectin, the fibronectin-
binding activity of blastocysts remains extremely low until
they are exposed to fibronectin for at least 1 h (Schultz and
Armant, 1995). Therefore, trafficking of aVh3 and a5h1 to
the surface of trophoblast cells is, in itself, insufficient for
strong adhesion to fibronectin. However, after ligand-
mediated upregulation by fibronectin, fibronectin-binding
activity is inhibited by antibodies that recognize aVh3 ora5h1; evidence that they contribute an essential element of
the adhesion mechanism.
In the presence of brefeldin A, fibronectin fails to
upregulate fibronectin-binding activity of adhesion compe-
tent blastocysts (Table 2), revealing a requirement for
additional protein trafficking after a5h1 insertion in the
apical cell surface (Schultz and Armant, 1995). Competitive
inhibition experiments indicate no increase in receptor
affinity (IC50) upon exposure to fibronectin, suggesting that
some fully active receptors are present before exposure, but
the majority of receptors are inactive. Hypotheses that might
account for the increased adhesive activity include, (1) the
number of fibronectin receptors on the apical cell surface is
increased, (2) additional integrin subtypes are recruited to
the apical surface, and (3) fibronectin receptors must be
reorganized with other proteins into adhesion complexes.
Blastocysts treated with fibronectin show no readily
apparent change in the expression of a5h1 or aVh3 on
their surface (Schultz et al., 1997), suggesting that the first
hypothesis does not fully account for the altered adhesive-
ness. However, the second hypothesis is supported by the
discovery of a third fibronectin-binding integrin that
trafficks to the apical surface of the trophoblast following
exposure to fibronectin on GD7 (Rout et al., 2004). The
third hypothesis could prove valid, as well, since the
cytoplasmic domains of integrins must interact with
cytoskeletal and signaling components to promote adhesion
(Sastry and Burridge, 2000). Indeed, disruption of the actin
cytoskeleton during exposure to fibronectin prevents the
upregulation of fibronectin activity (Schultz and Armant,
1995).
The platelet-associated integrin aIIbb3 strengthens
trophoblast adhesion to fibronectin
Preimplantation embryos express mRNA encoding the
alpha subunit of the integrin, aIIbh3 (Schultz et al., 1997),
which is associated primarily with cells of the megakar-
yocytic lineage (Ginsberg et al., 1993; Phillips et al., 1988).
In platelets, aIIbh3 binds fibrinogen during thrombus
formation, although its recognition of fibronectin andFig. 3. Transactivation of ErbB receptors by G protein-coupled receptors in
trophoblast cells. (A) LPA, and other agonists of G protein-coupled
receptors, mobilizes intracellular Ca2+ through the IP3 receptor (IP3-R)
after activating phospholipase C (PLC). (B) The increased Ca2+ concen-
tration induces trafficking of HB-EGF to the plasma membrane, where it is
cleaved by metalloproteinases (MP). (C) HB-EGF is then able to bind its
receptor in an autocrine loop. Experimental evidence points to Erb4 as the
primary receptor for HB-EGF (Paria et al., 1999; Wang et al., 2000).
Intracellular Ca2+ levels are again raised, this time by influx through N-type
Ca2+ channels (N). A recent report by Wang et al. (2003) suggests that
voltage-gated channels might be inhibited in the presence of high
concentrations of anandamide (AN), blocking this autocrine pathway.
Protein kinase C (PKC) and calmodulin (CAM) operate downstream of
Ca2+ to accelerate a5h1 trafficking to the plasma membrane. As a result,
blastocysts are adhesion competent approximately 1 day earlier than in
unstimulated embryos (Wang et al., 2000).
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tin, von Willebrand factor, and thrombospondin, is probably
also physiologically relevant for hemostasis (Savage et al.,
1996). Semi-quantitative assessment of aIIb mRNA during
preimplantation development reveals an apparent fivefold
increase in gene expression during blastocyst formation that
is blocked by a-amanitin (Rout et al., 2004), suggesting that
aIIb is among the gene products transcribed during
cavitation that later direct trophoblast outgrowth (Table 2).
Immunofluorescence microscopy reveals aIIb in focal
adhesions of trophoblast cells outgrowing on fibronectin
(Rout et al., 2004; Yelian et al., 1995), as expected of an
integrin that mediates adhesion to fibronectin. Most
interesting was the observation that aIIb remains intra-
cellular after aV and a5 have translocated to the apical
surface of trophoblast cells on GD7; however, upon
exposure to fibronectin, there is a significant increase in
aIIb at the blastocyst surface (Rout et al., 2004). In support
of its role in trophoblast adhesion, a function-blocking
antibody against the aIIb subunit inhibits fibronectin-bind-
ing activity (Rout et al., 2004).
The trafficking of aIIb to the apical surface of the
trophoblast coincides with the second period of sensitivity
to brefeldin A (Table 2). As the blastocyst becomes
adhesion competent, intracellular vesicles accumulate in
mural trophoblast cells; however, they are absent after
exposure to fibronectin (Wang et al., 2002). Brefeldin A
inhibits vesicle depletion induced by fibronectin, consistentFig. 4. Integrin trafficking during trophoblast development. (A) In the early blasto
trophoblast cells, whereas a5h1 (red circles) and aIIb subunits (black circles) are
competent blastocysts, a5h1 has been inserted into the apical plasma membrane
binding to a5h1, initiates intracellular signaling (*) required for trafficking of aIIb
activity is strengthened. (C) During early postimplantation development, aIIbh3 is
expressed in primary TGCs adhering to the Reichert’s membrane (left) and in se
migrating trophoblast cells suggests a model (right) in which the h3 integrins are
leading edge of cells, where they presumably attach the plasma membrane to ECM
cells to allow forward movement.with a mechanism involving their insertion into the plasma
membrane. Thus, a strong correlation exists between vesicle
translocation, aIIb trafficking, and the upregulation of
fibronectin-binding activity. The content of the intracellular
vesicles is unknown, but it is tempting to speculate that they
deliver to the apical plasma membrane aIIb and other
proteins required for strong adhesion. The studies by Rout et
al. (2004) and Wang et al. (2002) suggest that aIIb
trafficking is a key step in establishing strong adhesion
between trophoblast cells and fibronectin (Figs. 4A,B).
Examination of embryo implantation sites reveals aIIb
localized in primary TGCs of the parietal yolk sac adhering
to the Reichert’s membrane on E5.5 (Rout et al., 2004). By
E6.5, aIIb also appears in migrating secondary TGCs as
they differentiate near the margins of the EPC. During
implantation, aIIbh3-mediated adhesion could initially
anchor mural trophoblast cells to the uterine wall, and
may later function in secondary TGC migratory activity
(Fig. 4C).
Cooperative activities of fibronectin receptors
As mural trophoblast cells acquire adhesive activity,
some division of labor can be discerned among the
fibronectin-binding integrins. According to antibody inhib-
ition studies (Rout et al., 2004; Schultz and Armant, 1995),
contributions from three fibronectin-binding integrins,
aVh3, aIIbh3, and a5h1, are required to achieve strongcyst, aVh3 (white circles) is present at the apical surface of non-adhesive
localized either intracellularly or at the basal cell surface. (B) In adhesion
of trophoblast cells. Integrin ligation by fibronectin (FN), particularly its
subunits to the apical surface. Once aIIbh3 is available, fibronectin-binding
the predominant fibronectin-binding integrin of trophoblast cells. It is highly
condary TGCs migrating at the periphery of the EPC. In vitro analysis of
primarily responsible for motility. They appear in focal adhesions near the
. Focal adhesions are disassembled in the middle and at the trailing edge of
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contribution of additional integrins that recognize fibronec-
tin, in particular a8h1 and other aV integrins, has yet to be
examined. Culturing blastocysts on fibrinogen, which is a
poor substrate for a5h1, in the presence of function-
blocking antibodies against h3 to eliminate aVh3 and
aIIbh3 activity completely abolishes trophoblast outgrowth
(Rout et al., 2004), suggesting that these three integrins
function as the principal receptors for fibronectin.
Trophoblast outgrowth on fibronectin is inhibited almost
completely by an antibody against h3 or a combination of
antibodies against aV and aIIb, whereas inhibition of a5h1
has no significant effect on migration. From this result, it
appears that the h3 integrins are primarily responsible for
migratory activity. Anti-aIIb antibody disrupts focal adhe-
sions of trophoblast cells, displacing them from the
migrating edge of the cell. The redistribution of focal
adhesions to the center of cells could convert them from
migratory to stationary. While there has been much attention
paid to the promotion of cell invasion by aVh3 (Chatterjee
and Chatterjee, 2001; Huang et al., 2000; Leavesley et al.,
1992; Marshall and Hart, 1996), more studies are needed to
understand the role of aIIbh3 in trophoblast migration. It
has come to light in recent years that aIIb expression is not
restricted to the megakaryocyte lineage, and that aIIbh3
serves a critical function in the motility of highly invasive
tumors (Chen et al., 1997; Trikha et al., 2002). The
documented activity of aVh3 and aIIbh3 in other invasive
cell types is in keeping with their essential function in
trophoblast migration.
Ligation of a5h1 influences the initiation of trophoblast
outgrowth (Rout et al., 2004). Fibrinogen, which binds only
h3 integrins, supports trophoblast outgrowth after a
substantial delay and upregulates the fibronectin-binding
activity of intact blastocysts at a rate three times slower than
fibronectin. Mice lacking the h1 gene produce primary
TGCs that adhere to and outgrow on fibronectin (Stephens
et al., 1995), consistent with the ability of fibrinogen to
support outgrowth. While the h3 integrins can operate in the
absence of a5h1, antibody inhibition demonstrates that
a5h1 most efficiently initiates the pathway that establishes
strong adhesion (Rout et al., 2004).
Although none of these fibronectin-binding integrins are
indispensable for trophoblast outgrowth or implantation
(Hynes, 1996), the accumulated evidence indicates that the
default pathway in wild type trophoblast cells relies on
a5h1 signaling to upregulate adhesion, aIIbh3 to mediate
strong adhesion (Figs. 4A,B), and the h3 integrins for cell
motility (Fig. 4C). The survival and invasive integrity of
primary TGCs in mutant mice lacking fibronectin or its
integrin receptors suggests that functional redundancies in
the developmental program ensure the success of this
critical step. It is interesting that trophoblast cells can
manage a bwork aroundQ when an integrin gene is deleted,
but they are considerably less agile when inhibitory
antibodies are introduced immediately prior to blastocystoutgrowth. Perhaps there is a point at which the embryo
commits to an adhesive mechanism incorporating the
available integrin genes. The use of RNA interference
(Svoboda et al., 2001) to knock down integrin transcripts
might have advantages over gene knockouts as an approach
to understanding how integrins are recruited for specific
functions, although these experiments are complicated
somewhat by the disparity between the periods of integrin
synthesis and function in peri-implantation embryos.
Cellular recognition of ECM components
Trophoblast adhesion to the ECM in vivo is complex,
considering that the cells initially adhere to the epithelial
basement membrane, migrate throughout the decidua and
finally invade uterine blood vessels. Invasion would be
facilitated by an efficient mechanism to recruit adhesive
receptors as trophoblast cells encounter various ECM
components. The ligand-mediated upregulation of tropho-
blast adhesion to fibronectin could operate as a fibronectin
sensor that activates its cognate receptors. Together with
sensors for other ECM components, invading trophoblast
cells could rapidly adapt within a heterogeneous uterine
ECM.
The ECM-dependent selectivity of integrin activation can
be demonstrated by measuring fibronectin-binding activity
after exposing blastocysts to either fibronectin or laminin.
Only fibronectin upregulates fibronectin-binding activity
(Wang et al., 2002). Conversely, laminin, but not fibronec-
tin, can upregulate laminin binding activity (Schultz and
Armant, unpublished). These results support the idea that
contact with different components of the ECM activates the
appropriate receptors at the surface of trophoblast cells. This
example of physiological fine-tuning during trophoblast
differentiation may reflect an increased reliance after
blastocyst formation on environmental cues over a rigid
developmental program. Recent studies of trophoblast
adhesion to fibronectin have begun to shed light on the
biochemical basis of ECM recognition, which incorporates
an autocrine signaling mechanism.Autocrine signaling in trophoblast cells contacting
fibronectin
The ability of integrins to mediate intracellular signaling
upon ligation by ECM components (Kornberg et al., 1991)
has been known for over a decade to regulate cell growth,
adhesion, motility, and differentiation (Aplin et al., 1998;
Burridge and Chrzanowska-Wodnicka, 1996; Hynes, 1992).
Autocrine signaling involving integrins includes both the
initiation and transduction of intracellular signals. Integrin
ligation produces boutside-in signalingQ through integrin
clustering and association with cytoplasmic proteins that
initiate intracellular biochemical cascades (Fig. 5A). Signals
originating within cells can activate cytoplasmic proteins
Fig. 5. Hypothetical model of autocrine signaling in adhesion competent
trophoblast cells exposed to fibronectin. (A) With ligation of a5h1 by
fibronectin (FN), cytoplasmic proteins associate with integrin aggregates at
the plasma membrane. Protein tyrosine kinases (PTK) phosphorylate PLC-
g within this complex, leading to the production of IP3 and diacylglycerol
(DAG). IP3 binds to the IP3 receptor (IP3-R), releasing stored Ca2+ into the
cytoplasm. During development to the adhesion competent stage, intra-
cellular vesicles accumulate in mural trophoblast cells. It is hypothesized
that the vesicles contain aIIbh3 and other proteins that promote cell
adhesion. (B) With the elevation of intracellular Ca2+, calmodulin (CAM) is
activated. Depending on the isoform, PKC may be activated by DAG or
Ca2+. Signaling by both proteins is required for the upregulation of
fibronectin-binding activity. Ca2+ signaling is needed for the depletion
(apparent trafficking, solid arrows from PKC and CAM) of the intracellular
vesicles. CAM and PKC could also activate aIIbh3 after its trafficking to
the apical plasma membrane (dashed arrows). Presumably, aIIbh3 is
integrated into a nascent adhesion complex linked to elements of the actin
cytoskeleton, which strengthens adhesion to fibronectin.
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function, a process termed binside-out signalingQ (Fig. 5B).
Ligand-mediated upregulation of fibronectin-binding activ-
ity in trophoblast cells is an example of integrin autocrine
signaling.
The participation of integrins in the upregulation of
fibronectin-binding activity can be demonstrated by directly
ligating a5h1 or aVh3 with appropriate antibodies, whichincreases binding activity to the same extent as fibronectin
(Wang et al., 2002). Integrins become clustered in the
plasma membrane upon ligation by fibronectin, which
recruits protein tyrosine kinases, their substrates and other
signaling proteins to associate in focal adhesion complexes
with cytoskeletal elements of the cortical cytoplasm
(Miyamoto et al., 1995). Focal adhesion complexes mediate
adhesion at the basal surface of cells in culture. Occupied
integrins can also aggregate with signaling and cytoskeletal
proteins at the apical cell surface, as demonstrated by
Miyamoto et al. (1995). The same process could occur at the
apical surface of trophoblast cells in blastocysts exposed to
fibronectin in vitro or contacting fibronectin in the
endometrial ECM during implantation (see Fig. 5).
In addition to protein tyrosine phosphorylation (Korn-
berg et al., 1991), early reports demonstrated that integrin
ligation could elevate intracellular levels of Ca2+ in
lymphocytes (Pardi et al., 1989), neutrophils (Ng-Sikorski
et al., 1991), platelets (Smith et al., 1991), and endothelial
cells (Schwartz, 1993). Ligation of fibronectin receptors on
the surface of mouse blastocysts induces an immediate
increase in intracellular Ca2+ that is sustained over a 30- to
60-min period (Wang et al., 2002). Suppression of Ca2+
signaling by pretreating embryos with the intracellular Ca2+
chelator BAPTA-AM inhibits the upregulation of fibronec-
tin-binding activity by FN-120. Moreover, pharmacological
elevation of intracellular Ca2+ upregulates fibronectin-bind-
ing activity and induces vesicle depletion in the mural
trophoblast. These experiments show that Ca2+ signaling
induced by integrin ligation is both necessary and sufficient
to strengthen trophoblast adhesion to fibronectin.
Integrins elevate intracellular Ca2+ levels either through
influx or release from intracellular Ca2+ stores (McNamee et
al., 1993; Sjaastad et al., 1996; Somogyi et al., 1994; Wu et
al., 1998). In adrenal glomerulosa cells, fibronectin ligation
of a5h1 or aVh3 elevates intracellular Ca2+ by a
mechanism involving release from intracellular stores
through the IP3 receptor (Campbell et al., 2003). Phospho-
lipase C-g (PLC-g) is among the cytoplasmic proteins that
colocalize with clustered integrins (Miyamoto et al., 1995).
Its phosphorylation by protein tyrosine kinases that also
associate with aggregated integrins (e.g., Src, FAK) could
activate PLC-g to produce IP3 (discussed in Wang and
Armant, 2002). In mouse blastocysts, the ligand-mediated
upregulation of fibronectin-binding activity and associated
Ca2+ transients are blocked by antagonists of protein
tyrosine kinases, PLC and the IP3 receptor, but not by
inhibition of Ca2+ influx or voltage-gated Ca2+ channels
(Wang, Mayernik, Kilburn, and Armant, in submission).
This information suggests a mechanism of outside-in
integrin signaling (Fig. 5A). In this scheme, integrin ligation
by fibronectin activates associated protein tyrosine kinases
and PLC-g to generate IP3, which activates IP3 receptors
that release stored Ca2+ into the cytoplasm.
Integrin downstream signaling leads to inside-out
signaling, as depicted in Fig. 5B. As in the Ca2+-dependent
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fibronectin-induced upregulation of adhesion requires both
calmodulin and protein kinase C activities (Wang et al.,
2002). Calmodulin is directly activated by Ca2+ (Lu and
Means, 1993) and calmodulin-dependent proteins can alter
integrin binding activity (Pomies et al., 1995). Protein
kinase C is recruited to integrins clustered by fibronectin
(Miyamoto et al., 1995) where it could be activated by
diacylglycerol or Ca2+ mobilized through the IP3 receptor.
Once active, protein kinase C could upregulate integrin
binding activity. Protein kinase C-a activates aIIbh3
during platelet aggregation (Tabuchi et al., 2003), suggest-
ing the intriguing idea that a similar process occurs in the
trophoblast. Additionally, both calmodulin and protein
kinase C regulate exocytosis and protein trafficking (Chen
et al., 1999). Calmodulin is required for essential steps in
the fusion of secretory vesicles with the plasma membrane
(Quetglas et al., 2000; Peters and Mayer, 1998). Delivery of
proteins to the plasma membrane is stimulated by the
activity of protein kinase C (Lan et al., 2001), particularly
the h isoform (Long et al., 2001; Marinari et al., 2003;
Nechushtan et al., 2000). The protein kinase C isoform that
regulates fibronectin-binding activity in trophoblast cells
has not yet been identified, nor have the critical proteins
downstream of it or calmodulin. Several isoforms of protein
kinase C are expressed by the early blastocyst stage and
most appear to accumulate in the apical or junctional plasma
membranes of the trophectoderm (Eckert et al., 2004;
Pauken and Capco, 2000). These or other protein kinase C
isoforms that are expressed by the late blastocyst stage
could mediate the inside-out signaling pathway. During
peri-implantation development, it appears that the second
messenger Ca2+, operating through established downstream
pathways, orchestrates trophoblast adhesive differentiation
by initiating the sequential trafficking of critical proteins
into the plasma membrane (Figs. 3 and 5). Whether other
aspects of trophoblast phenotype are impacted by this
process remains to be determined.Concluding remarks
The developing blastocyst has proven to be an
informative model for investigating the ontogeny of cell
adhesion during mammalian embryogenesis. Reminiscent
of the early zygote, the intrinsic developmental program
of primary trophoblast cells is directed by transcripts or
proteins synthesized at an earlier stage (Schultz et al.,
1997). Post-translational processing and trafficking of
gene products, rather than biosynthesis, determines the
onset of trophoblast adhesiveness in preparation for
blastocyst implantation. One caveat of this paradigm is
a lack of information about the integrity of other
embryonic functions, such as proliferation and endoredu-
pication, in embryos blocked for transcription or trans-
lation. Ca2+ signaling plays a major role in advancingblastocyst development to the adhesive stage. Transit
through key steps in differentiation is initiated by the
activity of Ca2+-dependent proteins, including calmodulin
and protein kinase C, that trigger the delivery of proteins
needed for cell adhesion to the apical cell domain. The
regulation of trophoblast adhesion independently of gene
activation enables cells to rapidly adapt to variations in
the local environment. As trophoblast cells migrate
through a heterogeneous ECM, adhesion is maintained
by switching integrin receptors. The integrin switching
hypothesis (Damsky et al., 1994) suggests that trophoblast
cells recognize the molecular composition of the local
ECM and modify their cell surfaces to optimally interact
with it for purposes of both embryo anchorage and cell
invasion.
Evidence discussed here suggests that trophoblast
adhesion is orchestrated through a series of trafficking
events that position receptors at the embryo surface for
subsequent signaling, which initiates further trafficking
(see Fig. 1B). Paracrine signaling by secreted uterine
agonists (e.g., LPA, calcitonin) advance blastocyst devel-
opment, perhaps in part through protein trafficking.
Trafficking of ErbB4 to the surface of early blastocysts
(E4.0) is required before HB-EGF becomes an effective
agonist (Wang et al., 2000). Ca2+ influx downstream of
HB-EGF binding to ErbB4 drives the insertion of a5h1
into the apical plasma membrane, enabling integrin signal-
ing (Wang et al., 2000). Once the embryo contacts
fibronectin within the endometrial ECM, integrin signaling
initiates the Ca2+-dependent events that translocate aIIb to
the apical surface and strengthen adhesion. Signaling at
each of these steps is dependent on a previous trafficking
event, providing a glimpse of the developmental program
that guides the conversion of primary trophoblast cells to
an adhesion competent phenotype.
Many unanswered questions remain regarding the
appropriateness of generalizing processes observed during
the upregulation of fibronectin-binding activity to other
ECM components or to later stages of trophoblast develop-
ment. Functions unrelated to trophoblast adhesion and
outgrowth could depend on de novo gene expression. It
would be interesting to know whether intracellular signaling
initiated by integrin ligation differentially regulates embry-
onic gene expression. While the emergence of trophoblast
subtypes during placentation is certainly regulated by
specific genes (Cross, 2000; Rossant and Cross, 2001),
regulation by extrinsic factors operating at the post-
transcriptional level remains an open and intriguing
possibility. The paradigm represented by fibronectin-
mediated adhesion in the implanting blastocyst suggests
how positional information could be translated to direct the
rapid emergence of trophoblast subtype populations during
pattern formation within the developing placenta. The
innovation of new technologies for investigating tropho-
blast stem cells in vitro (Gerami-Naini et al., 2004; Tanaka
et al., 1998; Xu et al., 2002) presents an opportunity to
D.R. Armant / Developmental Biology 280 (2005) 260–280276examine the role of extrinsic factors on trophoblast differ-
entiation into its various subtypes.Acknowledgments
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